Chinese Medical Technology Firm Huayin Health Secures $85M In Series C Round
Huayin Health, a Guangzhou-based medical technology firm, has completed a Series C round financing of RMB600 million (US$85 million) led…
Healthcare
Temasek Leads $70M Series C Round In Chinese Biotech Firm Abbisko
Abbisko Therapeutics, a Chinese oncology focused biopharmaceutical company, recently announced the completion of a US$70 million Series C financing, led…
Hillhouse Leads $60M Series B Funding Round In Chinese IASO Biotherapeutics
IASO Biotherapeutics recently announced the completion of US$60 million in series B financing led by GL Ventures, a venture capital…
Chinese AI Medical Imaging Firm Yizhun Intelligent Completes $14M Series B Round
Chinese AI medical imaging company Yizhun Intelligent has recently completed a Series B round financing of nearly RMB100 million (US$14.14…
Chinese Biotech Firm Harbour BioMed Raises $75 Million In Series B+ Round
Shanghai-based biopharmaceutical company Harbour BioMed today announced successful completion of a Series B+ round financing of US$75 million. New investors…
New Survey Shows Confidence In Hong Kong Solid Amidst Coronavirus
While over nine in 10 members (92%) of the international business community in Hong Kong feel the novel coronavirus (Covid-19)…
Nine Trends To Watch In China’s Senior Care Industry
The year 2020 has begun in an unexpected way. The rapid spread of the new coronary pneumonia (NCP), which originated…
Coronavirus Outbreak Pushes 200 Million In China To Video Conferencing
Nearly 200 million people across China began remote work via cloud office software this week, pushing companies including Alibaba, Huawei,…
Chinese Color Contact Lens Startup 4iNLOOK Secures New Round
Chinese color contact Lens brand 4iNLOOK recently announced that it has completed two rounds of financing in the past year.…
Chinese Point-Of-Care Testing Startup Tisenc Secures New Round
Shenzhen Tisenc Medical Equipment Co. , Ltd., a Chinese point-of-care testing platform, announced the completion of a series B round…
Shanghai Bioprofile Secures Pre-A Funding Round
Proteome, metabonomics technology service provider Shanghai Bioprofile announced the completion of a ten million RMB pre-A round of financing, funded…
Chinese Biotech Firm Transcenta Raises $100M Round
Transcenta Holding, a Chinese biopharmaceutical company with the capabilities of drug discovery, process development, clinical development and process integration, announced…
Qiming Venture Co-Leads Series A Round In Sunny Dental
Dental clinic Sunny Dental has raised a series A fiancing round worth tens of millions of RMB led by Qiming…
Cancer Precision Diagnosis Firm 3D Medicines Raises RMB280M
A Chinese cancer precision diagnostics firm 3D Medicines recently completed a 280 million yuan (US$40 million) financing for its diagnostic…
CF PharmTech Completes RMB630M Series E Round
CF Pharmtech, Inc. recently successfully completed series E round financing of RMB630 million (US$90 million). This round of financing is…
Chinese Genetic Testing Company Geneseeq Completes $114M Series D Round
Chinese cancer genetic testing service company Geneseeq has raised RMB800 million (US$114.3 million) in a series D round of financing…
Chinese Biotech Firm Innovative Cellular Therapeutics Completes New Funding Round
Shanghai-based biotechnology company Innovative Cellular Therapeutics (ICT) has completed a new round of financing from LH Ventures, a venture capital…
China Merchants Capital Leads $60M Series C Round In Chinese Medical Equipment Service Provider
Kedu Healthcare Tech, a Shanghai-based medical equipment service provider, has raised US$60 million in a series C round of financing…
Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm KeChow Pharma
Shanghai KeChow Pharma, a Chinese biopharmaceutical company focused on novel drug discover, has raised US$45million in a series C round…
Huagai Capital Leads $60M Series A Round In Chinese Biological Medicine Start-up
Chinese biological medicine start-up JOINN Biologics has raised US$60 million in a series A round of financing led by the…
Chinese Drug Development Firm Ribo Completes $28M Series C1 Round
Suzhou Ribo Life Science Co. Ltd. (Ribo), a siRNA drug development company in China, announced today that it has raised…
Tencent, Wu Capital Lead $142M Series D+ Round In Chinese Medical Service Platform Medbanks
Chinese medical service platform Medbanks has raised about RMB1 billion (US$142 million) in a series D+ round of financing led…
Matrix Partners China Leads $14M Series C Round In Chinese Biotech Firm Lansionbio
Nanjing-based biotech firm Lansion Biotechnology (Lansionbio) has raised nearly RMB100 million (US$14 million) in a series C round of financing…
Matrix Partners-Linked Fund Joins $100M Series C Round In Medical Devices Provider Peijia Medical
Peijia Medical Co., Ltd, interventional medical products provider, announces on Wednesday that it has completed US$100 million in a series…
Volcanics Venture, CCV Lead $15M Series B Round In Chinese Digital Marketing Solutions Provider
Naxions, a Chinese provider of digital marketing solutions for pharmaceutical companies, has completed a US$15 million series B round of…
SCGC-Backed Innovative Antibody Drug Firm Gets $150M Funding From Sino Biopharm
Akeso Biopharma, an innovative biotechnology company, announced that it has raised nearly US$150 million in a series D funding round…
Yuexiu-Backed Biotech Firm Yikon Gets $31M Funding From KingMed Diagnostics-Linked Fund
Yikon Genomics, a reproductive health-focused biotech firm, announces on Monday that it has completed RMB220 million (US$31.3 million) in a…
Chinese Biotech Firm Denovo Biopharma Nets $42M In Series B Round
Denovo Biopharma, a Chinese biotechnology company providing a novel biomarker solution to personalize drug development, has raised RMB300 million (US$42.6…
Hillhouse-Backed Biotech Firm I-Mab Eyes $100M In US IPO
I-Mab Biopharma, a Chinese-clinical stage biopharmaceutical company, has filed for an up to US$100 million IPO of American Depository Shares…
Matrix Leads $15M Series A1 Funding In Anti-Tumor Drug Firm QnQuality
QnQuality Pharmaceuticals Ltd., a Shanghai-based drug R&D company, announces on Monday that it has raised US$15 million in a series…
Goldman Sachs Leads $62M Series D Round In Chinese CRO Firm Fountain Medical
Fountain Medical, a Chinese clinical-stage contract research organization (CRO) offering one-stop services to pharmaceutical and medical device companies, has raised…